Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing

Saravana P Selvanathan1, Garrett T Graham1, Hayriye V Erkizan1

  • 1Department of Oncology and Pediatrics, Georgetown University, Washington, DC 20057;

Insights

Ewing sarcoma oncoprotein EWS-FLI1 drives cancer by altering messenger RNA (mRNA) splicing. Inhibiting EWS-FLI1 with YK-4-279 normalizes splicing patterns, offering a potential therapeutic strategy for Ewing sarcoma.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Messenger RNA (mRNA) splicing is crucial for gene expression, with splice site selection modulated by various proteins.
  • Ewing sarcoma (ES) is driven by the EWS-FLI1 oncoprotein, which interacts with spliceosomal complexes.
  • Dysregulation of posttranscriptional gene regulation, including alternative splicing, is implicated in oncogenesis.

Purpose of the Study:

  • To investigate the impact of the EWS-FLI1 oncoprotein on mRNA splicing and posttranscriptional gene regulation in Ewing sarcoma.
  • To identify specific genes and splicing factors modulated by EWS-FLI1.
  • To evaluate the therapeutic potential of targeting EWS-FLI1-mediated splicing alterations.

Main Methods:

  • Exon array and RNA-sequencing (RNA-seq) were employed to analyze gene expression and splicing patterns.
  • CLIP-seq experiments were conducted to identify RNA-binding motifs of EWS-FLI1.
  • Protein-protein interaction studies were performed to assess EWS-FLI1 binding to splicing factors.
  • The effect of the EWS-FLI1 inhibitor YK-4-279 on splicing was evaluated.
  • Analysis of patient samples was performed using exon arrays.

Main Results:

  • EWS-FLI1 significantly alters the splicing of genes involved in oncogenesis, such as CLK1, CASP3, PPFIBP1, and TERT.
  • EWS-FLI1 binds to splicing factors like DDX5, hnRNP K, and PRPF6, directly influencing splicing.
  • Reduction of EWS-FLI1 leads to altered TERT splicing, impacting telomerase activity.
  • The inhibitor YK-4-279 mimics the splicing alterations observed upon EWS-FLI1 reduction.
  • Splicing patterns in ES patient samples resemble those in cell line models expressing EWS-FLI1.

Conclusions:

  • Systemic alternative splicing is an oncogenic process driven by EWS-FLI1 in Ewing sarcoma.
  • EWS-FLI1's modulation of mRNA splicing contributes to oncogenesis.
  • Targeting EWS-FLI1 interactions with splicing machinery, potentially via inhibitors like YK-4-279, represents a viable therapeutic strategy.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.9K
RNA Splicing01:32

RNA Splicing

21.0K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
27.3K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.6K
Pre-mRNA Processing: RNA Splicing01:32

Pre-mRNA Processing: RNA Splicing

7.5K
What is Gene Expression?01:36

What is Gene Expression?

A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised  of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then...
12.6K